publications

Article

Trends in secondary prevention of coronary heart disease in Tunisia: prevention of recurrences of MI and stroke.

, 2012

Electronic Journal of Digital Entreprise, 7, Décembre 2012, 361 - 366, Mars 2012

Résumé

Objectives

The survival benefits achieved by prescription of antiplatelet agents, B-adrenoreceptor antagonists (beta-blockers), angiotensin II receptor blockers (ARB), and lipid lowering agents in patients surviving the myocardial infarction (MI) have been well documented in large clinical trial. Despite well-established benefits, these pharmacological agents continue to be underutilized. The main objective of this study was to evaluate the progress of cardiovascular secondary prevention practices in Tunisia.

Methods